tirzepatide program For Weight Loss ✨ REAL RESULTS. REAL CONFIDENCE.

Eat smaller, more frequent meals rather than three large ones

On 15 November 2023, a spokesperson for Novo Nordisk, which manufactures semaglutide, told The Pharmaceutical Journal : Novo Nordisk has filed for a label update of Wegovy [semaglutide] in the UK, United States and EU to include an indication of reducing the risk of major adverse cardiovascular events (cardiovascular death, non-fatal heart attack or non-fatal stroke) in people with an initial BMI [body mass index] of 27 kg/m 2 or greater and established cardiovascular disease

Heres what to be aware of when considering the side effects of Mounjaro vs

According to the Medicines and Healthcare products Regulatory Agency (MHRA) approved Summary of Product Characteristics (SmPC), belching (eructation) is not specifically listed as a common adverse effect for Ozempic, though it is listed as a 'common' side effect (affecting up to 1 in 10 people) for Wegovy